Anna Capaul
Associate | Attorney at law
T. +41 58 510 92 55
anna.capaul@advestra.ch
vCard
LinkedIn
Anna Capaul’s practice focuses on M&A and other corporate transactions. In addition, she advises companies on corporate and general commercial law as well as employment law matters.
She regularly advises corporate clients, private equity, venture capital and other investors on domestic and cross-border acquisitions and disposals, investments, joint ventures and other M&A transactions.
In addition, clients seek her assistance on general corporate and commercial law as well as employment law matters.
M&A
- Advising Cactus Life Sciences on the acquisition of nspm and eluSCIdate
- Advising medermis on the acquisition of Ästhetik- und Laserzentrum Zürichsee
- Advising Breitling on the acquisition of Universal Genève
- Advising KPIT on its strategic investment in AirConsole
- Advising Ironwood Pharmaceuticals on its public tender offer for VectivBio
- Advising Ardian on the acquisition of a stake in the Mimacom Flowable Group
- Advising Andermatt Swiss Alps on investment by Vail Resorts
Capital Markets
- Advising Orascom Development Holding on its rights offering
- Advising Credit Suisse and UBS on the IPO of the first Swiss SPAC, VT5 Acquisition Company AG
- Advising Credit Suisse and UBS on the IPO of medmix
Financing
- Advising a group of finance parties on the refinancing of certain debt and on the provision of USD 400 million in new capital for Diebold Nixdorf, Incorporated
- Foreign Associate at Greenberg Traurig, London (2024-2025)
- Associate at Advestra (since 2021)
- Associate at Bär & Karrer (2018 – 2020)
- University of St. Gallen (HSG): CAS in Law and Management (2020)
- Admitted to the bar of the Canton of Zurich (2018)
- Law clerk at the district court of Meilen (2015 – 2016)
- Junior associate at Bär & Karrer (2014 – 2015)
- University of Zurich: MLaw (2014)
- University of Lucerne: BLaw (2012)
- Zurich Bar Association (ZAV)
- German
- English
- All Swiss courts
- Advestra advises EvlaBio on its EUR 21 million seed financing round
- Advestra advises German Equity Partners IV on Sale of Swiss Healthcare Group Uroviva to Affidea
- Advestra advises medermis clinics on its strategic partnership with Hautwerk
- Advestra advises Breitling on the acquisition of Gallet
- Advestra advises Xylem Inc. on the acquisition of Heusser Water Solutions AG
- Advestra advises Liberta Partners on the acquisition of a majority stake in Avenir
- Advestra advises MIGx Management and Shareholders on a Partnership with GREENPEAK Partners
- Advestra advises LOGEX on the acquisition of INMED
- Advestra advises Swiss Re on the sale of iptiQ's European Property and Casualty insurance business to Allianz Direct
- Advestra advises the sellers on the sale of IntiQuan AG to ProductLife Group